Works by Kanellias, Nikolaos

Results: 69
    1

    Re-evaluation of Mayo 2004 and revised Mayo 2012 staging in patients with AL amyloidosis in the era of new therapies.

    Published in:
    2025
    By:
    • Theodorakakou, Foteini;
    • Fotiou, Despina;
    • Spiliopoulou, Vasiliki;
    • Migkou, Magdalini;
    • Malandrakis, Panagiotis;
    • Ntanasis-Stathopoulos, Ioannis;
    • Roussou, Maria;
    • Kanellias, Nikolaos;
    • Eleutherakis-Papaiakovou, Evangelos;
    • Solia, Eirini;
    • Papanikolaou, Asimina;
    • Gakiopoulou, Charikleia;
    • Courraud, Julie;
    • Nikolaou, Panagiota-Efstathia;
    • Giannouli, Stavroula;
    • Gavriatopoulou, Maria;
    • Terpos, Evangelos;
    • Dimopoulos, Meletios-Athanasios;
    • Kastritis, Efstathios
    Publication type:
    Letter to the Editor
    2

    Daratumumab May Attenuate Cardiac Dysfunction Related to Carfilzomib in Patients with Relapsed/Refractory Multiple Myeloma: A Prospective Study.

    Published in:
    Cancers, 2021, v. 13, n. 20, p. 5057, doi. 10.3390/cancers13205057
    By:
    • Terpos, Evangelos;
    • Stamatelopoulos, Kimon;
    • Makris, Nikolaos;
    • Georgiopoulos, Georgios;
    • Ntanasis-Stathopoulos, Ioannis;
    • Gavriatopoulou, Maria;
    • Laina, Ageliki;
    • Eleutherakis-Papaiakovou, Evangelos;
    • Fotiou, Despina;
    • Kanellias, Nikolaos;
    • Malandrakis, Panagiotis;
    • Delialis, Dimitris;
    • Andreadou, Ioanna;
    • Kastritis, Efstathios;
    • Dimopoulos, Meletios A.
    Publication type:
    Article
    3

    Aberrant Plasma Cell Contamination of Peripheral Blood Stem Cell Autografts, Assessed by Next-Generation Flow Cytometry, Is a Negative Predictor for Deep Response Post Autologous Transplantation in Multiple Myeloma; A Prospective Study in 199 Patients.

    Published in:
    Cancers, 2021, v. 13, n. 16, p. 4047, doi. 10.3390/cancers13164047
    By:
    • Kostopoulos, Ioannis V.;
    • Eleutherakis-Papaiakovou, Evangelos;
    • Rousakis, Pantelis;
    • Ntanasis-Stathopoulos, Ioannis;
    • Panteli, Chrysanthi;
    • Orologas-Stavrou, Nikolaos;
    • Kanellias, Nikolaos;
    • Malandrakis, Panagiotis;
    • Liacos, Christine-Ivy;
    • Papaioannou, Nikos E.;
    • Papanota, Aristea-Maria;
    • Migkou, Magdalini;
    • Fotiou, Despina;
    • Gavriatopoulou, Maria;
    • Angelis, Nikolaos V.;
    • Kastritis, Efstathios;
    • Dimopoulos, Meletios-Athanasios;
    • Tsitsilonis, Ourania E.;
    • Terpos, Evangelos
    Publication type:
    Article
    4

    A Molecular Signature of Circulating MicroRNA Can Predict Osteolytic Bone Disease in Multiple Myeloma.

    Published in:
    Cancers, 2021, v. 13, n. 15, p. 3877, doi. 10.3390/cancers13153877
    By:
    • Papanota, Aristea-Maria;
    • Tsiakanikas, Panagiotis;
    • Kontos, Christos K.;
    • Malandrakis, Panagiotis;
    • Liacos, Christine-Ivy;
    • Ntanasis-Stathopoulos, Ioannis;
    • Kanellias, Nikolaos;
    • Gavriatopoulou, Maria;
    • Kastritis, Efstathios;
    • Avgeris, Margaritis;
    • Dimopoulos, Meletios-Athanasios;
    • Scorilas, Andreas;
    • Terpos, Evangelos
    Publication type:
    Article
    5

    Carfilzomib Improves Bone Metabolism in Patients with Advanced Relapsed/Refractory Multiple Myeloma: Results of the CarMMa Study.

    Published in:
    Cancers, 2021, v. 13, n. 6, p. 1257, doi. 10.3390/cancers13061257
    By:
    • Terpos, Evangelos;
    • Ntanasis-Stathopoulos, Ioannis;
    • Katodritou, Eirini;
    • Kyrtsonis, Marie-Christine;
    • Douka, Vassiliki;
    • Spanoudakis, Emmanouil;
    • Papatheodorou, Athanasios;
    • Eleutherakis-Papaiakovou, Evangelos;
    • Kanellias, Nikolaos;
    • Gavriatopoulou, Maria;
    • Makras, Polyzois;
    • Kastritis, Efstathios;
    • Dimopoulos, Meletios A;
    • Atanackovic, Djordje
    Publication type:
    Article
    6

    Deep Phenotyping Reveals Distinct Immune Signatures Correlating with Prognostication, Treatment Responses, and MRD Status in Multiple Myeloma.

    Published in:
    Cancers, 2020, v. 12, n. 11, p. 3245, doi. 10.3390/cancers12113245
    By:
    • Papadimitriou, Konstantinos;
    • Tsakirakis, Nikolaos;
    • Malandrakis, Panagiotis;
    • Vitsos, Panagiotis;
    • Metousis, Andreas;
    • Orologas-Stavrou, Nikolaos;
    • Ntanasis-Stathopoulos, Ioannis;
    • Kanellias, Nikolaos;
    • Eleutherakis-Papaiakovou, Evangelos;
    • Pothos, Panagiotis;
    • Fotiou, Despina;
    • Gavriatopoulou, Maria;
    • Kastritis, Efstathios;
    • Dimopoulos, Meletios-Athanasios;
    • Terpos, Evangelos;
    • Tsitsilonis, Ourania E.;
    • Kostopoulos, Ioannis V.
    Publication type:
    Article
    7

    The neutralizing antibody response post COVID-19 vaccination in patients with myeloma is highly dependent on the type of anti-myeloma treatment.

    Published in:
    Blood Cancer Journal, 2021, v. 11, n. 8, p. 1, doi. 10.1038/s41408-021-00530-3
    By:
    • Terpos, Evangelos;
    • Gavriatopoulou, Maria;
    • Ntanasis-Stathopoulos, Ioannis;
    • Briasoulis, Alexandros;
    • Gumeni, Sentiljana;
    • Malandrakis, Panagiotis;
    • Fotiou, Despina;
    • Papanagnou, Eleni-Dimitra;
    • Migkou, Magdalini;
    • Theodorakakou, Foteini;
    • Roussou, Maria;
    • Eleutherakis-Papaiakovou, Evangelos;
    • Kanellias, Nikolaos;
    • Trougakos, Ioannis P.;
    • Kastritis, Efstathios;
    • Dimopoulos, Meletios A.
    Publication type:
    Article
    8

    Carfilzomib-associated renal toxicity is common and unpredictable: a comprehensive analysis of 114 multiple myeloma patients.

    Published in:
    Blood Cancer Journal, 2020, v. 10, n. 11, p. 1, doi. 10.1038/s41408-020-00381-4
    By:
    • Fotiou, Despina;
    • Roussou, Maria;
    • Gakiopoulou, Charikleia;
    • Psimenou, Erasmia;
    • Gavriatopoulou, Maria;
    • Migkou, Magdalini;
    • Kanellias, Nikolaos;
    • Dialoupi, Ioanna;
    • Eleutherakis-Papaiakovou, Evangelos;
    • Giannouli, Stavroula;
    • Delavinia, Christina;
    • Efstathiou, Kostantinos;
    • Kontogiannis, Sofoklis;
    • Terpos, Evangelos;
    • Dimopoulos, Meletios A.;
    • Kastritis, Efstathios
    Publication type:
    Article
    9

    The Role of Low Dose Whole Body CT in the Detection of Progression of Patients with Smoldering Multiple Myeloma.

    Published in:
    Blood Cancer Journal, 2020, v. 10, n. 9, p. N.PAG, doi. 10.1038/s41408-020-00360-9
    By:
    • Gavriatopoulou, Maria;
    • Βoultadaki, Andriani;
    • Koutoulidis, Vassilis;
    • Ntanasis-Stathopoulos, Ioannis;
    • Bourgioti, Charis;
    • Malandrakis, Panagiotis;
    • Fotiou, Despina;
    • Migkou, Magdalini;
    • Kanellias, Nikolaos;
    • Eleutherakis-Papaiakovou, Evangelos;
    • Kastritis, Efstathios;
    • Terpos, Evangelos;
    • Dimopoulos, Meletios A.;
    • Moulopoulos, Lia-Angela
    Publication type:
    Article
    10

    Consolidation with carfilzomib, lenalidomide, and dexamethasone (KRd) following ASCT results in high rates of minimal residual disease negativity and improves bone metabolism, in the absence of bisphosphonates, among newly diagnosed patients with multiple myeloma

    Published in:
    2020
    By:
    • Gavriatopoulou, Maria;
    • Terpos, Evangelos;
    • Ntanasis-Stathopoulos, Ioannis;
    • Malandrakis, Panagiotis;
    • Eleutherakis-Papaiakovou, Evangelos;
    • Papatheodorou, Athanasios;
    • Kanellias, Nikolaos;
    • Migkou, Magdalini;
    • Fotiou, Despina;
    • Dialoupi, Ioanna;
    • Roussou, Maria;
    • Kokkali, Nikoletta-Aikaterini;
    • Kastritis, Efstathios;
    • Dimopoulos, Meletios A.
    Publication type:
    Letter
    11

    Impact of daratumumab on stem cell mobilization and collection, engraftment and early post-transplant complications among multiple myeloma patients undergoing autologous stem cell transplantation.

    Published in:
    Leukemia & Lymphoma, 2023, v. 64, n. 13, p. 2140, doi. 10.1080/10428194.2023.2253479
    By:
    • Eleutherakis Papaiakovou, Evangelos;
    • Terpos, Evangelos;
    • Kanellias, Nikolaos;
    • Migkou, Magdalini;
    • Gavriatopoulou, Maria;
    • Ntanasis-Stathopoulos, Ioannis;
    • Fotiou, Despoina;
    • Malandrakis, Panagiotis;
    • Theodorakakou, Foteini;
    • Spiliopoulou, Vasiliki;
    • Kostopoulos, Ioannis V.;
    • Tsitsiloni, Ourania;
    • Tsirigotis, Panagiotis;
    • Dimopoulos, Meletios-Athanasios;
    • Kastritis, Efstathios
    Publication type:
    Article
    12

    Patterns of target organ amyloid deposition in patients with AL amyloidosis; role for diagnosis and prognosis.

    Published in:
    Leukemia & Lymphoma, 2023, v. 64, n. 6, p. 1212, doi. 10.1080/10428194.2023.2197537
    By:
    • Fotiou, Despina;
    • Theodorakakou, Foteini;
    • Malandrakis, Panagiotis;
    • Ntanasis-Stathopoulos, Ioannis;
    • Gavriatopoulou, Maria;
    • Kanellias, Nikolaos;
    • Migkou, Magdalini;
    • Eleutherakis-Papaiakovou, Evangelos;
    • Papanikolaou, Asimina;
    • Gakiopoulou, Charikleia;
    • Terpos, Evangelos;
    • Dimopoulos, Meletios Athanasios;
    • Kastritis, Efstathios
    Publication type:
    Article
    13
    14
    15

    Vulnerability variables among octogenerian myeloma patients: a single-center analysis of 110 patients.

    Published in:
    Leukemia & Lymphoma, 2019, v. 60, n. 3, p. 619, doi. 10.1080/10428194.2018.1509323
    By:
    • Gavriatopoulou, Maria;
    • Fotiou, Despina;
    • Koloventzou, Ursula;
    • Roussou, Maria;
    • Migkou, Magdalini;
    • Ntanasis-Stathopoulos, Ioannis;
    • Kanellias, Nikolaos;
    • Ziogas, Dimitrios C.;
    • Panagiotidis, Ioannis;
    • Gika, Dimitra;
    • Eleutherakis-Papaiakovou, Evangelos;
    • Terpos, Evangelos;
    • Kastritis, Efstathios;
    • Dimopoulos, Meletios Athanasios
    Publication type:
    Article
    16

    Coexistence of leishmaniasis and multiple myeloma in the era of monoclonal antibody (anti-CD38 or anti-SLAMF7) containing triplets: one shared story of two exceptional cases.

    Published in:
    2018
    By:
    • Ziogas, Dimitrios C.;
    • Terpos, Evangelos;
    • Gavriatopoulou, Maria;
    • Migkou, Magdalini;
    • Fotiou, Despoina;
    • Roussou, Maria;
    • Kanellias, Nikolaos;
    • Tatouli, Ioanna;
    • Eleutherakis-Papaiakovou, Evangelos;
    • Panagiotidis, Ioannis;
    • Ntanasis-Stathopoulos, Ioannis;
    • Kastritis, Efstathios;
    • Dimopoulos, Meletios A.
    Publication type:
    Case Study
    17
    18

    Low circulating tumor cell levels correlate with favorable outcomes and distinct biological features in multiple myeloma.

    Published in:
    American Journal of Hematology, 2024, v. 99, n. 10, p. 1887, doi. 10.1002/ajh.27414
    By:
    • Kostopoulos, Ioannis V.;
    • Ntanasis‐Stathopoulos, Ioannis;
    • Rousakis, Pantelis;
    • Malandrakis, Panagiotis;
    • Panteli, Chrysanthi;
    • Eleutherakis‐Papaiakovou, Evangelos;
    • Angelis, Nikolaos;
    • Spiliopoulou, Vasiliki;
    • Syrigou, Rodanthi‐Eleni;
    • Bakouros, Panagiotis;
    • Dimitrakopoulou, Georgia;
    • Fotiou, Despina;
    • Migkou, Magdalini;
    • Kanellias, Nikolaos;
    • Paschalidis, Nikolaos;
    • Gavriatopoulou, Maria;
    • Kastritis, Efstathios;
    • Dimopoulos, Meletios‐Athanasios;
    • Tsitsilonis, Ourania E.;
    • Terpos, Evangelos
    Publication type:
    Article
    19

    Belantamab mafodotin, lenalidomide, and dexamethasone in transplant‐ineligible patients with newly diagnosed multiple myeloma: Analysis of belantamab mafodotin‐associated ocular adverse events and their impact on daily functioning from the part 1 of a phase 1/2 study

    Published in:
    American Journal of Hematology, 2024, v. 99, n. 3, p. 502, doi. 10.1002/ajh.27219
    By:
    • Gavriatopoulou, Maria;
    • Ntanasis‐Stathopoulos, Ioannis;
    • Malandrakis, Panagiotis;
    • Fotiou, Despina;
    • Migkou, Magdalini;
    • Theodorakakou, Foteini;
    • Spiliopoulou, Vasiliki;
    • Kanellias, Nikolaos;
    • Eleutherakis‐Papaiakovou, Evangelos;
    • Roussou, Maria;
    • Psarros, Giorgos;
    • Kastritis, Efstathios;
    • Dimopoulos, Meletios A.;
    • Terpos, Evangelos
    Publication type:
    Article
    20

    Prospective phase 2 trial of daratumumab with dexamethasone in patients with relapsed/refractory multiple myeloma and severe renal impairment or on dialysis: The DARE study.

    Published in:
    American Journal of Hematology, 2023, v. 98, n. 9, p. E226, doi. 10.1002/ajh.27001
    By:
    • Kastritis, Efstathios;
    • Terpos, Evangelos;
    • Symeonidis, Argiris;
    • Labropoulou, Vasiliki;
    • Delimpasi, Sosana;
    • Mancuso, Katia;
    • Zamagni, Elena;
    • Katodritou, Eirini;
    • Rivolti, Elena;
    • Kyrtsonis, Marie‐Christine;
    • Roussou, Maria;
    • Fotiou, Despina;
    • Theodorakakou, Foteini;
    • Ntanasis‐Stathopoulos, Ioannis;
    • Hatjiharissi, Evdoxia;
    • Kanellias, Nikolaos;
    • Migkou, Magdalini;
    • Cheliotis, Giorgos;
    • Manousou, Kyriaki;
    • Gavriatopoulou, Maria
    Publication type:
    Article
    21

    Improved survival of patients with primary plasma cell leukemia with VRd or daratumumab‐based quadruplets: A multicenter study by the Greek myeloma study group.

    Published in:
    American Journal of Hematology, 2023, v. 98, n. 5, p. 730, doi. 10.1002/ajh.26891
    By:
    • Katodritou, Eirini;
    • Kastritis, Efstathios;
    • Dalampira, Dimitra;
    • Delimpasi, Sosana;
    • Spanoudakis, Emmanouil;
    • Labropoulou, Vasiliki;
    • Ntanasis‐Stathopoulos, Ioannis;
    • Gkioka, Annita‐Ioanna;
    • Giannakoulas, Nikos;
    • Kanellias, Nikolaos;
    • Papadopoulou, Theodosia;
    • Sevastoudi, Aggeliki;
    • Michalis, Eyrydiki;
    • Papathanasiou, Maria;
    • Kotsopoulou, Maria;
    • Sioni, Anastasia;
    • Triantafyllou, Theodora;
    • Daiou, Aikaterini;
    • Papadatou, Mavra;
    • Kyrtsonis, Marie‐Christine
    Publication type:
    Article
    22

    Chromosome 1q21 aberrations identify ultra high‐risk myeloma with prognostic and clinical implications.

    Published in:
    American Journal of Hematology, 2022, v. 97, n. 9, p. 1142, doi. 10.1002/ajh.26639
    By:
    • Kastritis, Efstathios;
    • Migkou, Magdalini;
    • Dalampira, Dimitra;
    • Gavriatopoulou, Maria;
    • Fotiou, Despina;
    • Roussou, Maria;
    • Kanellias, Nikolaos;
    • Ntanasis‐Stathopoulos, Ioannis;
    • Malandrakis, Panagiotis;
    • Theodorakakou, Foteini;
    • Sevastoudi, Aggeliki;
    • Eleutherakis‐Papaiakovou, Evangelos;
    • Triantafyllou, Theodora;
    • Terpos, Evangelos;
    • Katodritou, Eirini;
    • Dimopoulos, Meletios A.
    Publication type:
    Article
    23

    Kinetics of anti‐SARS‐CoV‐2 neutralizing antibodies development after BNT162b2 vaccination in patients with amyloidosis and the impact of therapy.

    Published in:
    American Journal of Hematology, 2022, v. 97, n. 1, p. E27, doi. 10.1002/ajh.26406
    By:
    • Kastritis, Efstathios;
    • Terpos, Evangelos;
    • Evangelakou, Zoi;
    • Theodorakakou, Foteini;
    • Fotiou, Despina;
    • Manola, Maria S.;
    • Gianniou, Despoina D.;
    • Bagratuni, Tina;
    • Kanellias, Nikolaos;
    • Migkou, Magdalini;
    • Gavriatopoulou, Maria;
    • Trougakos, Ioannis P.;
    • Dimopoulos, Meletios A.
    Publication type:
    Article
    24

    Cell‐free DNA analysis for the detection of MYD88 and CXCR4 mutations in IgM monoclonal gammopathies; an update with clinicopathological correlations.

    Published in:
    American Journal of Hematology, 2020, v. 95, n. 6, p. E148, doi. 10.1002/ajh.25802
    By:
    • Ntanasis‐Stathopoulos, Ioannis;
    • Bagratuni, Tina;
    • Gavriatopoulou, Maria;
    • Patseas, Dimitrios;
    • Liacos, Christine;
    • Kanellias, Nikolaos;
    • Fotiou, Despina;
    • Tsiligkeridou, Eleni;
    • Andreatou, Amalia;
    • Mavrianou‐Koutsoukou, Nefeli;
    • Migkou, Magdalini;
    • Eleutherakis‐Papaiakovou, Evangelos;
    • Roussou, Maria;
    • Terpos, Evangelos;
    • Kastritis, Efstathios;
    • Dimopoulos, Meletios A.
    Publication type:
    Article
    25

    Bone marrow biopsy in low‐risk monoclonal gammopathy of undetermined significance reveals a novel smoldering multiple myeloma risk group.

    Published in:
    American Journal of Hematology, 2019, v. 94, n. 5, p. E146, doi. 10.1002/ajh.25441
    By:
    • Bustoros, Mark;
    • Kastritis, Efstathios;
    • Sklavenitis‐Pistofidis, Romanos;
    • Liu, Chia‐Jen;
    • Hornburg, Kalvis;
    • Kanellias, Nikolaos;
    • Kim, Geon;
    • Liu, David;
    • Gavriatopoulou, Maria;
    • Marinac, Catherine R.;
    • Roussou, Maria;
    • Migkou, Magdalini;
    • Noonan, Kimberly;
    • Reyes, Kaitlen;
    • Rivotto, Bradley;
    • Neuse, Carl Jannes;
    • Ziogas, Dimitrios C.;
    • Laubach, Jacob;
    • Terpos, Evangelos;
    • Anderson, Kenneth C.
    Publication type:
    Article
    26

    Consolidation therapy with the combination of bortezomib and lenalidomide (VR) without dexamethasone in multiple myeloma patients after transplant: Effects on survival and bone outcomes in the absence of bisphosphonates.

    Published in:
    American Journal of Hematology, 2019, v. 94, n. 4, p. 400, doi. 10.1002/ajh.25392
    By:
    • Terpos, Evangelos;
    • Kastritis, Efstathios;
    • Ntanasis‐Stathopoulos, Ioannis;
    • Christoulas, Dimitrios;
    • Papatheodorou, Athanasios;
    • Eleutherakis‐Papaiakovou, Evangelos;
    • Kanellias, Nikolaos;
    • Fotiou, Despina;
    • Ziogas, Dimitrios C.;
    • Migkou, Magdalini;
    • Roussou, Maria;
    • Trougakos, Ioannis P.;
    • Gavriatopoulou, Maria;
    • Dimopoulos, Meletios A.
    Publication type:
    Article
    27

    Efficacy and immune modulation associated with the addition of IMiDs to Daratumumab backbone in multiple myeloma patients refractory to both drug classes: resetting synergistic activity.

    Published in:
    Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-00988-x
    By:
    • Kostopoulos, Ioannis V.;
    • Fotiou, Despina;
    • Gavriatopoulou, Maria;
    • Rousakis, Pantelis;
    • Ntanasis-Stathopoulos, Ioannis;
    • Panteli, Chrysanthi;
    • Malandrakis, Panagiotis;
    • Migkou, Magdalini;
    • Angelis, Nikolaos;
    • Kanellias, Nikolaos;
    • Eleutherakis-Papaiakovou, Evangelos;
    • Theodorakakou, Foteini;
    • Krevvata, Maria;
    • Terpos, Evangelos;
    • Dimopoulos, Meletios-Athanasios;
    • Tsitsilonis, Ourania;
    • Kastritis, Efstathios
    Publication type:
    Article
    28

    Characteristics and Outcomes of Patients With Relapsed/Refractory Multiple Myeloma After Exposure to Lenalidomide in First Line of Therapy: A Single Center Database Review in Greece.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2024, v. 24, n. 7, p. 468, doi. 10.1016/j.clml.2024.03.003
    By:
    • Kastritis, Efstathios;
    • Ntanasis-Stathopoulos, Ioannis;
    • Theodorakakou, Foteini;
    • Migkou, Magdalini;
    • Roussou, Maria;
    • Malandrakis, Panagiotis;
    • Kanellias, Nikolaos;
    • Eleutherakis-Papaiakovou, Evangelos;
    • Fotiou, Despina;
    • Spiliopoulou, Vassiliki;
    • Gavriatopoulou, Maria;
    • Patel, Sachin;
    • Majer, Istvan;
    • Boukis, Christos;
    • Fetani, Andriani;
    • Dimopoulos, Meletios A.;
    • Terpos, Evangelos
    Publication type:
    Article
    29

    P-209: High response rates with IMiD retreatment post anti-CD38 exposure in patients with Multiple Myeloma.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S154, doi. 10.1016/S2152-2650(21)02336-3
    By:
    • Ntanasis-Stathopoulos, Ioannis;
    • Gavriatopoulou, Maria;
    • Malandrakis, Panagiotis;
    • Fotiou, Despina;
    • Migkou, Magdalini;
    • Kanellias, Nikolaos;
    • Eleutherakis-Papaiakovou, Evangelos;
    • Theodorakakou, Foteini;
    • Roussou, Maria;
    • Terpos, Evangelos;
    • Kastritis, Efstathios;
    • Dimopoulos, Meletios-Athanasios
    Publication type:
    Article
    30

    P-127: Patients with Multiple Myeloma on treatment with Anti-CD38 or Anti-BCMA agents have a suboptimal humoral response following COVID-19 vaccination.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S104, doi. 10.1016/S2152-2650(21)02254-0
    By:
    • Terpos, Evangelos;
    • Gavriatopoulou, Maria;
    • Ntanasis-Stathopoulos, Ioannis;
    • Briasoulis, Alexandros;
    • Gumeni, Sentiljana;
    • Malandrakis, Panagiotis;
    • Fotiou, Despina;
    • Papanagnou, Eleni-Dimitra;
    • Migkou, Magdalini;
    • Theodorakakou, Foteini;
    • Roussou, Maria;
    • Eleutherakis-Papaiakovou, Evangelos;
    • Kanellias, Nikolaos;
    • Trougakos, Ioannis;
    • Kastritis, Efstathios;
    • Dimopoulos, Meletios-Athanasios
    Publication type:
    Article
    31

    Early Relapse After Autologous Transplant Is Associated With Very Poor Survival and Identifies an Ultra-High-Risk Group of Patients With Myeloma.

    Published in:
    2020
    By:
    • Kastritis, Efstathios;
    • Roussou, Maria;
    • Eleutherakis-Papaiakovou, Evangelos;
    • Gavriatopoulou, Maria;
    • Migkou, Magdalini;
    • Gika, Dimitra;
    • Fotiou, Despina;
    • Kanellias, Nikolaos;
    • Ziogas, Dimitrios C.;
    • Ntanasis-Stathopoulos, Ioannis;
    • Mparmparousi, Despoina;
    • Gatou, Anastasia;
    • Katopi, Despina;
    • Manios, Efstathios;
    • Liontos, Michail;
    • Giannouli, Stavroula;
    • Tsirigotis, Panagiotis;
    • Terpos, Evangelos;
    • Dimopoulos, Meletios A.
    Publication type:
    journal article
    32

    Screening for Gaucher disease in patients with plasma cell dyscrasias.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e327, doi. 10.1016/j.clml.2019.09.537
    By:
    • Ntanasis-Stathopoulos, Ioannis;
    • Gavriatopoulou, Maria;
    • Fotiou, Despina;
    • Kanellias, Nikolaos;
    • Migkou, Magdalini;
    • Eleutherakis-Papaiakovou, Evangelos;
    • Kastritis, Efstathios;
    • Dimopoulos, Meletios A.;
    • Terpos, Evangelos
    Publication type:
    Article
    33

    Primary Treatment of Light Chain (AL) Amyloidosis With Bortezomib, Lenalidomide and Dexamethasone (VRD) or with Bortezomib, Cyclophosphamide and Dexamethasone (VCD/CyBorD): efficacy and toxicity.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e320, doi. 10.1016/j.clml.2019.07.322
    By:
    • Kastritis, Efstathios;
    • Gavriatopoulou, Maria;
    • Fotiou, Despina;
    • Kanellias, Nikolaos;
    • Migkou, Magdalini;
    • Tselegkidi, Maria Irini;
    • Marinaki, Smaragdi;
    • Psimenou, Erasmia;
    • Ntanasis-Stathopoulos, Ioannis;
    • Gakiopoulou, Harikleia;
    • Papanota, Aristea-Maria;
    • Terpos, Evangelos;
    • Dimopoulos, Meletios A.
    Publication type:
    Article
    34

    Longitudinal Evaluation of Minimal Residual Disease in Patients with Multiple Myeloma who Achieve Complete Response After First Line Therapy.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e185, doi. 10.1016/j.clml.2019.09.310
    By:
    • Kostopoulos, Ioannis V.;
    • Kastritis, Efstathios;
    • Papanota, Aristea-Maria;
    • Micheli, Paraskevi;
    • Malandrakis, Panagiotis;
    • Ntanasis-Stathopoulos, Ioannis;
    • Fotiou, Despina;
    • Kanellias, Nikolaos;
    • Migkou, Magdalini;
    • Eleutherakis-Papaiakovou, Evangelos;
    • Gavriatopoulou, Maria;
    • Tsitsilonis, Ourania;
    • Dimopoulos, Meletios A.;
    • Terpos, Evangelos
    Publication type:
    Article
    35

    Absence of Aberrant Plasma Cells in the Apheresis Product Predicts for Minimal Residual Disease Negativity after Autologous Transplantation in Myeloma Patients Who Receive First Line Therapy.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e184, doi. 10.1016/j.clml.2019.09.309
    By:
    • Terpos, Evangelos;
    • Kostopoulos, Ioannis V.;
    • Eleutherakis-Papaiakovou, Evangelos;
    • Papanota, Aristea-Maria;
    • Micheli, Paraskevi;
    • Malandrakis, Panagiotis;
    • Kanellias, Nikolaos;
    • Ntanasis-Stathopoulos, Ioannis;
    • Fotiou, Despina;
    • Migkou, Magdalini;
    • Liacos, Christine-Ivy;
    • Gavriatopoulou, Maria;
    • Kastritis, Efstathios;
    • Tsitsilonis, Ourania;
    • Dimopoulos, Meletios A.
    Publication type:
    Article
    36

    Incidence of Skeletal-Related Events at Diagnosis and at the Time of First Relapse in 463 Patients with Multiple Myeloma Who Received First Line Treatment in a Single Center.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. S333, doi. 10.1016/j.clml.2019.07.325
    By:
    • Terpos, Evangelos;
    • Kanellias, Nikolaos;
    • Moulopoulos, Lia A.;
    • Christoulas, Dimitrios;
    • Gavriatopoulou, Maria;
    • Migkou, Magdalini;
    • Bagratuni, Tina;
    • Koutoulidis, Vasilios;
    • Kastritis, Efstathios;
    • Dimopoulos, Meletios A.
    Publication type:
    Article
    37

    Primary Treatment of Light Chain (AL) Amyloidosis with Bortezomib, Lenalidomide and Dexamethasone (VRD).

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. S331, doi. 10.1016/j.clml.2019.07.322
    By:
    • Kastritis, Efstathios;
    • Dialoupi, Ioanna;
    • Gavriatopoulou, Maria;
    • Roussou, Maria;
    • Kanellias, Nikolaos;
    • Fotiou, Despina;
    • Ntanasis-Stathopoulos, Ioannis;
    • Papadopoulou, Elektra;
    • Ziogas, Dimitrios C.;
    • Stamatelopoulos, Kimon;
    • Manios, Efstathios;
    • Ntalianis, Argyrios;
    • Eleutherakis-Papaiakovou, Evangelos;
    • Papanikolaou, Asimina;
    • Migkou, Magdalini;
    • Gakiopoulou, Charikleia;
    • Psimenou, Erasmia;
    • Tselegkidi, Marini;
    • Tsitsilonis, Ourania;
    • Trougakos, Ioannis
    Publication type:
    Article
    38

    Circulating Soluble Urokinase-Type Plasminogen Activator Receptor Levels Reflect Renal Function in Newly Diagnosed Patients with Multiple Myeloma who Are Treated with Bortezomib-Based Therapy.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. S325, doi. 10.1016/j.clml.2019.07.310
    By:
    • Papanota, Aristea-Maria;
    • Kastritis, Efstathios;
    • Papassotiriou, Gerasimos-Petros;
    • Kanellias, Nikolaos;
    • Eleutherakis-Papaiakovou, Evangelos;
    • Margeli, Alexandra;
    • Migkou, Magdalini;
    • Ntanasis-Stathopoulos, Ioannis;
    • Gavriatopoulou, Maria;
    • Psimenou, Erasmia;
    • Papassotiriou, Ioannis;
    • Dimopoulos, Meletios A.;
    • Terpos, Evangelos
    Publication type:
    Article
    39

    Elevated vWF Antigen Serum Levels Are Associated With Poor Prognosis, and Decreased Circulating ADAMTS-13 Antigen Levels Are Associated With Increased IgM Levels and Features of WM but not Increased vWF Levels in Patients With Symptomatic WM.

    Published in:
    2019
    By:
    • Gavriatopoulou, Maria;
    • Terpos, Evangelos;
    • Ntanasis-Stathopoulos, Ioannis;
    • Papasotiriou, Ioannis;
    • Fotiou, Despoina;
    • Migkou, Magdalini;
    • Roussou, Maria;
    • Kanellias, Nikolaos;
    • Ziogas, Dimitrios;
    • Dialoupi, Ioanna;
    • Eleutherakis Papaiakovou, Evangelos;
    • Kastritis, Efstathios;
    • Dimopoulos, Meletios Athanasios
    Publication type:
    journal article
    40
    41

    Outcomes of Consecutive Patients With Newly Diagnosed Myeloma Requiring Dialysis: Dialysis Independence is Associated with Rapid Myeloma Response and Predicts for Longer Survival.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e62, doi. 10.1016/j.clml.2017.03.114
    By:
    • Dimopoulos, Meletios Athanasios;
    • Pouli, Anastasia;
    • Roussou, Maria;
    • Gavriatopoulou, Maria;
    • Kanellias, Nikolaos;
    • Fotiou, Despina;
    • Migkou, Magdalini;
    • Eleutherakis-Papaiakovou, Evangelos;
    • Ziogas, Dimitrios C.;
    • Panagiotidis, Ioannis;
    • Psimenou, Erasmia;
    • Matsouka, Charis;
    • Mparmparousi, Despoina;
    • Giannouli, Stavroula;
    • Terpos, Evangelos;
    • Kastritis, Efstathios
    Publication type:
    Article
    42
    43

    Addition of Cyclophosphamide and Higher Doses of Dexamethasone Do Not Improve Outcomes of Patients With AL amyloidosis Treated With Bortezomib.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e65, doi. 10.1016/j.clml.2017.03.119
    By:
    • Gavriatopoulou, Maria;
    • Roussou, Maria;
    • Ziogas, Dimitrios C.;
    • Fotiou, Despina;
    • Migkou, Magdalini;
    • Eleutherakis-Papaiakovou, Evangelos;
    • Panagiotidis, Ioannis;
    • Kanellias, Nikolaos;
    • Psimenou, Erasmia;
    • Papadopoulou, Elektra;
    • Pamboucas, Constatntinos;
    • Gakiopoulou, Harikleia;
    • Tasidou, Anna;
    • Giannouli, Stavroula;
    • Terpos, Evangelos;
    • Dimopoulos, Meletios Athanasios;
    • Kastritis, Efstathios
    Publication type:
    Article
    44

    Prior Lenalidomide Resistance and the Impact of IMiD-free Interval in Patients Treated with Pomalidomide and Dexamethasone.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e115, doi. 10.1016/j.clml.2017.03.210
    By:
    • Dimopoulos, Meletios Athanasios;
    • Roussou, Maria;
    • Kanellias, Nikolaos;
    • Gavriatopoulou, Maria;
    • Migkou, Magdalini;
    • Panagiotidis, Ioannis;
    • Eleutherakis-Papaiakovou, Evangelos;
    • Ziogas, Dimitrios C.;
    • Fotiou, Despina;
    • Giannouli, Stavroula;
    • Tsirigotis, Panagiotis;
    • Mparmparousi, Despoina;
    • Matsouka, Charis;
    • Delimpasi, Sossana;
    • Terpos, Evangelos;
    • Kastritis, Efstathios
    Publication type:
    Article
    45
    46

    Thrombotic and bleeding complications in patients with AL amyloidosis.

    Published in:
    British Journal of Haematology, 2024, v. 204, n. 5, p. 1816, doi. 10.1111/bjh.19331
    By:
    • Fotiou, Despina;
    • Theodorakakou, Foteini;
    • Spiliopoulou, Sotiria;
    • Gavriatopoulou, Maria;
    • Migkou, Magdalini;
    • Kanellias, Nikolaos;
    • Eleutherakis‐Papaiakovou, Evangelos;
    • Malandrakis, Panagiotis;
    • Dialoupi, Ioanna;
    • Roussou, Maria;
    • Ntanasis‐Stathopoulos, Ioannis;
    • Terpos, Evangelos;
    • Dimopoulos, Meletios A.;
    • Kastritis, Efstathios
    Publication type:
    Article
    47

    Outcomes of patients with light chain (AL) amyloidosis after failure of daratumumab‐based therapy.

    Published in:
    British Journal of Haematology, 2023, v. 203, n. 3, p. 411, doi. 10.1111/bjh.19042
    By:
    • Theodorakakou, Foteini;
    • Fotiou, Despina;
    • Spiliopoulou, Vasiliki;
    • Roussou, Maria;
    • Malandrakis, Panagiotis;
    • Ntanasis‐Stathopoulos, Ioannis;
    • Migkou, Magdalini;
    • Eleutherakis‐Papaiakovou, Evangelos;
    • Kanellias, Nikolaos;
    • Papanikolaou, Asimina;
    • Gavriatopoulou, Maria;
    • Terpos, Evangelos;
    • Dimopoulos, Meletios A.;
    • Kastritis, Efstathios
    Publication type:
    Article
    48
    49
    50

    Pulmonary function abnormalities are common in patients with multiple myeloma and are independently associated with worse outcome.

    Published in:
    2019
    By:
    • Trakada, Georgia;
    • Kastritis, Efstathios;
    • Gavriatopoulou, Maria;
    • Velentza, Lemonia;
    • Fotiou, Despina;
    • Ziogas, Dimitrios C.;
    • Panagiotidis, Ioannis;
    • Eleutherakis-Papaiakovou, Evangelos;
    • Roussou, Maria;
    • Migkou, Magdalini;
    • Kanellias, Nikolaos;
    • Ntanasis-Stathopoulos, Ioannis;
    • Kallianos, Anastasios;
    • Terpos, Evangelos;
    • Dimopoulos, Meletios A.
    Publication type:
    journal article